Allergy Treatment Market: Industry Analysis and Forecast 2021-2027: by Type, Allergen Type, Products, End User and Region.

Allergy Treatment Market is anticipated to reach US$ 20.76 Bn. by 2027 from US$ 13.3 Bn. in 2020 at a CAGR of 7.7% during a forecast period. Allergies are immune system hypersensitivity reactions to chemicals that enter or come into contact with the human body. An allergen is a substance that induces an allergic response. Anaphylaxis, food allergies, asthma, conjunctivitis, eczema, eosinophilic disorders, and drug and insect allergies are all examples of allergic illnesses. The growing incidence of allergic illnesses is driving the global allergy treatment market. In the research, the revenue effect of the COVID -19 pandemic on leading firms, market followers, and market disrupters was examined, and the same is represented in our analysis. Allergy Treatment Market To know about the Research Methodology :- Request Free Sample Report In report, 2020 is considered a base year however 2020’s numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.

Allergy Treatment Market Dynamics

Rising self-medication cases, rising healthcare expenditure, an aging population, an increase in the number of government-sponsored awareness programs, and rising incidences of chronic diseases are expected to propel the allergy treatment market forward over the forecast period. Increasing R&D and increased knowledge of immunotherapy for the treatment of allergies among healthcare professionals and patients, on the other hand, are expected to provide profitable opportunities in the future. Increasing Preference for Self-Medication for Allergy Treatment to Boost Market Aeroallergens include tree weed, wheat, dust mite, soy, mold, prawns, eggs, and a variety of other food and non-edible items. Allergens can cause allergic rhinitis, asthma, hay fever, and atopic dermatitis, among other allergic diseases. Allergic reactions can include rashes, itching in the nose, eyes, and throat, stuffy nose, red and teary eyes, sneezing, and other symptoms. Aside from respiratory symptoms, allergies to particular foods can cause severe diarrhea, vomiting, and respiratory problems. It may potentially result in death, however, this is an uncommon occurrence. Restraints: Increased use of biosimilars, as well as safety and effectiveness concerns about the negative effects associated with heavy use of anti-allergy medications, are expected to hamper the allergy treatment market's growth.

Allergy Treatment Market Segmentation Analysis

By Type, in 2020, the rhinitis allergy segment contributed the most to the market, and this trend is expected to continue during the forecast period. This was ascribed to an increase in the global prevalence of allergic rhinitis. According to the European Academy of Allergy and Clinical Immunology (EAACI), rhinitis affected over 400 million individuals globally in 2018. Allergy Treatment Market

Allergy Treatment Market Regional Insight

In 2020, North America held a market share of 37.30 percent of the global allergy treatment market. Geographically, North America is the largest sector of the global allergy treatment market. The increasing incidence of allergies in the area, the mature market, increased knowledge of allergic disorders and expanding risk factors related to allergies have all contributed to the regions rise. Both the United States and Canada are developed economies with significant per capita healthcare spending. Both Countries have been overhauling their healthcare systems to make them more patient-centered, resulting in increased knowledge of personal health and disorders. North America has a high level of awareness of allergic disorders, which has contributed to the region's allergy treatment market. Immunotherapies, as well as epinephrine autoinjectors and inhalers, have increased the adoption of innovative medicines and medical devices for allergy control. According to the American Academy of Allergy, Asthma, and Immunology, about 27.2 million persons in the United States had allergic rhinitis in 2015, with another 26 million having asthma. This strong demand is expected to keep North America as the most profitable area for allergy treatment shareholders in the world. In addition to the United States, Canada's government is concentrating on giving Canadians the knowledge they need to make healthy and safe food choices. To achieve this aim, the CFIA (Canadian Food Inspection Agency) and Health Canada collaborate with provincial, municipal, and territorial partners as well as sectors. Furthermore, multiple medications are being developed in the United States, especially to treat various forms of allergies. Players in the market are concentrating their efforts on the development and introduction of new products. The US Food and Drug Administration approved Aimmune Therapeutics Inc.'s Biologics License Application (BLA) for AR101 for assessment in March 2019. (FDA). During the forecast period, the US allergy treatment market is expected to increase due to an emphasis on R&D, especially for the launch of improved products. Another region quickly gaining importance is the global allergy treatment market in Asia-Pacific. The progressive growth of the healthcare infrastructure, as well as greater awareness of advanced immunotherapy in allergy treatment, are reasons for its rising significance. The growing number of firms delivering immunotherapies across the region is one of the key reasons driving the rise of allergy treatment. Allergic rhinitis affects about 45 percent of the population in Europe between the ages of 20 and 45, and advances in allergy therapy are fueling this growth. Report Objectives: • Landscape analysis of the Allergy Treatment Market • competitive benchmarking • Past and current status of the industry with the forecasted market size and trends • Evaluation of potential key players that include market leaders, followers, and new entrants • Technology trends • Potential impact of micro-economic factors of the market • External and Internal factors affecting market have been analyzed The report also helps in understanding the Allergy Treatment Market dynamics, structure by analysing the market segments and project the Allergy Treatment Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Allergy Treatment Market make the report investor’s guide.

Allergy Treatment Market Scope: Inquire before buying

Allergy Treatment Market
Report Coverage Details
Base Year: 2020 Forecast Period: 2021-2027
Historical Data: 2016 to 2020 Market Size in 2020: US $ 13.3  Bn
Forecast Period 2021 to 2027 CAGR: 7.7 % Market Size in 2027: US $ 20.76  Bn.
Segments Covered: by Type • Eye Allergy • Food Allergy • Skin Allergy • Asthma • Rhinitis Treatment
by Allergen Type • Inhaled Allergens • Food Allergens • Other Allergens
by Products • Instruments • Consumables • Luminometers
by End-User • Diagnostic Laboratories • Hospital • Other End Users

Allergy Treatment Market by Region

• North America • Asia pacific • Europe • Middle East and Africa • South America

Allergy Treatment Market: Key Players

Allergopharma • Allergy Therapeutics • Alerpharma S.A • Allergon AB • Genentech Inc. • Allergan, Inc. • McNeil Consumer Healthcare • Schering-Plough Corporation • Meda Pharmaceuticals, Inc. • Collegium Pharmaceutical, Inc. • Vicks, and Sepracor, Inc. • Sanofi • Johnson & Johnson Services Inc • Novartis AG • Cipla Inc • Aurobindo Pharma • Zydus Cadila • Lupin • Mylan N.V. • Teva Pharmaceutical Industries Ltd • Dr. Reddy's Laboratories Ltd Frequently Asked Questions 1. What is the projected market size & growth rate of Allergy Treatment Market? Ans- Allergy Treatment Market was valued at USD 20.76 billion in 2020 and is projected to reach USD 13.3 billion by 2027, growing at a CAGR of 7.7% during the forecast period. 2. What are the key driving factor for the growth of Allergy Treatment Market? Ans- Rising self-medication cases, rising healthcare expenditure, an aging population, an increase in the number of government-sponsored awareness programs, and rising incidences of chronic diseases are expected to propel the allergy treatment market forward over the forecast period. 3. Which Region accounted for the largest Allergy Treatment Market share? Ans- In 2020, North America had a market share of 37.30 percent of the worldwide allergy treatment market. 4. What makes Asia Pacific a Lucrative Market for Allergy Treatment Market? Ans- The progressive growth of the healthcare infrastructure, as well as greater awareness of advanced immunotherapy in allergy treatment, are reasons for its rising significance. 5. What are the top players operating in Allergy Treatment Market? Ans- Allergopharma, Allergy Therapeutics, Alerpharma S.A, Allergon AB, Genentech Inc., and Allergan, Inc.
1. Global Allergy Treatment Market: Research Methodology 2. Global Allergy Treatment Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Allergy Treatment Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Allergy Treatment Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Allergy Treatment Market Segmentation 4.1 Global Allergy Treatment Market, By Type (2020-2027) • Eye Allergy • Food Allergy • Skin Allergy • Asthma • Rhinitis Treatment 4.2 Global Allergy Treatment Market, By Allergen Type (2020-2027) • Inhaled Allergens • Food Allergens • Other Allergens 4.3. European Allergy Treatment Market, By Products (2020-2027) • Instruments • Consumables • Luminometers 4.4. European Allergy Treatment Market, By End User (2020-2027) • Diagnostic Laboratories • Hospital • Other End Users 5. North America Allergy Treatment Market (2020-2027) 5.1 North American Allergy Treatment Market, By Type (2020-2027) • Eye Allergy • Food Allergy • Skin Allergy • Asthma • Rhinitis Treatment 5.2 North America Allergy Treatment Market, By Allergen Type (2020-2027) • Inhaled Allergens • Food Allergens • Other Allergens 5.3. European Allergy Treatment Market, By Products (2020-2027) • Instruments • Consumables • Luminometers 5.4. European Allergy Treatment Market, By End User (2020-2027) • Diagnostic Laboratories • Hospital • Other End Users 5.5. North America Allergy Treatment Market, by Country (2020-2027) • United States • Canada • Mexico 6. Asia Pacific Allergy Treatment Market (2020-2027) 6.1. Asia Pacific Allergy Treatment Market, By Type (2020-2027) 6.2. Asia Pacific Allergy Treatment Market, By Allergen Type (2020-2027) 6.3. European Allergy Treatment Market, By Products (2020-2027) 6.4. European Allergy Treatment Market, By End User (2020-2027) 6.5. Asia Pacific Allergy Treatment Market, by Country (2020-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Allergy Treatment Market (2020-2027) 7.1. Middle East and Africa Allergy Treatment Market, By Type (2020-2027) 7.2. Middle East and Africa Allergy Treatment Market, By Allergen Type (2020-2027) 7.3. European Allergy Treatment Market, By Products (2020-2027) 7.7. European Allergy Treatment Market, By End User (2020-2027) 7.5. Middle East and Africa Allergy Treatment Market, by Country (2020-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Allergy Treatment Market (2020-2027) 8.1. Latin America Allergy Treatment Market, By Type (2020-2027) 8.2. Latin America Allergy Treatment Market, By Allergen Type (2020-2027) 8.3. European Allergy Treatment Market, By Products (2020-2027) 8.4. European Allergy Treatment Market, By End User (2020-2027) 8.5 Latin America Allergy Treatment Market, by Country (2020-2027) • Brazil • Argentina • Rest Of Latin America 9. European Allergy Treatment Market (2020-2027) 9.1. European Allergy Treatment Market, By Type (2020-2027) 9.2. European Allergy Treatment Market, By Allergen Type (2020-2027) 9.3. European Allergy Treatment Market, By Products (2020-2027) 9.4. European Allergy Treatment Market, By End User (2020-2027) 9.5. European Allergy Treatment Market, by Country (2020-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. Allergopharma 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Allergopharma 10.3. Allergy Therapeutics 10.4. Alerpharma S.A 10.5. Allergon AB 10.6. Genentech Inc. 10.7. Allergan, Inc. 10.8. McNeil Consumer Healthcare 10.9. Schering-Plough Corporation 10.10. Meda Pharmaceuticals, Inc. 10.11. Collegium Pharmaceutical, Inc. 10.12. Vicks, and Sepracor, Inc. 10.13. Sanofi 10.14. Johnson & Johnson Services Inc 10.15. Novartis AG 10.16. Cipla Inc 10.17. Aurobindo Pharma 10.18. Zydus Cadila 10.19. Lupin 10.20. Mylan N.V. 10.21. Teva Pharmaceutical Industries Ltd 10.22. Dr. Reddy's Laboratories Ltd

About This Report

Report ID 37309
Category Healthcare
Published Date Nov 2019
Updated Date Nov 2021
Contact Us